(Q46824451)

25 December 2017

title

Photosensitizing and radiosensitizing effects of hypericin on human renal carcinoma cells in vitro (English)

1 reference

25 December 2017

1 reference

Johannes Theodor Wessels

1

1 reference

25 December 2017

Ann-Christin Busse

2

1 reference

25 December 2017

Margret Rave-Fränk

3

1 reference

25 December 2017

Stephan Zänker

4

1 reference

25 December 2017

Robert Hermann

5

1 reference

25 December 2017

Eckhardt Grabbe

6

1 reference

25 December 2017

Gerhard-Anton Müller

7

1 reference

25 December 2017

language of work or name

1 reference

1 January 2008

1 reference

25 December 2017

Photochemistry and Photobiology

published in

1 reference

25 December 2017

volume

84

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

228-235

1 reference

25 December 2017

Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Systemic therapy for renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Chemotherapy in metastatic renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Photophysical properties of Hypericum perforatum L. extracts--novel photosensitizers for PDT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Hypericin in cancer treatment: more light on the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Light-dependent inhibition of protein kinase C and superoxide generation of neutrophils by hypericin, an antiretroviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Hypericin--the facts about a controversial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Differential cytotoxic effects induced after photosensitization by hypericin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Apoptotic and anti-apoptotic signaling pathways induced by photodynamic therapy with hypericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

The effect of hypericin and hypocrellin-A on lipid membranes and membrane potential of 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Intrinsic radiation resistance in human chondrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Differential expression of protein kinase C epsilon protein in lung cancer cell lines by ionising radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Hypericin-an inhibitor of proteasome function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

Photosensitized inhibition of growth factor-regulated protein kinases by hypericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00225.X

10.1111/J.1751-1097.2007.00225.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017